Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) and Candel Therapeutics (NASDAQ:CADL – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Risk & Volatility Fennec Pharmaceuticals has a beta of 0.03, suggesting that its stock price is 97% less volatile than the S&P 500. Comparatively, Candel Therapeutics has a beta of 0.

https://www.dailypolitical.com/2023/01/08/candel-therapeutics-nasdaqcadl-versus-fennec-pharmaceuticals-nasdaqfenc-head-to-head-contrast.html

#dailypolitical